Back
Apogee Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
APGE
Apogee Therapeutics, Inc.
Last Price:
$84.40
Seasonality Move:
-11.77%
7 Day Trial
ALL ACCESS PASS
$
7
Apogee Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Apogee Therapeutics, Inc. has on average historically risen by 40.6% based on the past 2 years of stock performance.
-
Apogee Therapeutics, Inc. has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Apogee Therapeutics, Inc. Stock Undervalued?The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Apogee Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Apogee Therapeutics, Inc. has on average historically risen by 40.6% based on the past 2 years of stock performance.
Apogee Therapeutics, Inc. Stock Rating
Sell
44
Apogee Therapeutics, Inc. (APGE)
is a Sell
Is Apogee Therapeutics, Inc. overpriced?
-
Apogee Therapeutics, Inc. has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Apogee Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apogeetherapeutics.com
52-Week Data
52-Week High:
85.94
52-Week Low:
26.20
Prediction Charts
Market Cap:
5.8B
Price in USD:
84.34
Volume:
663.2K
Beta:
1.04
Technical Analysis
SMA50:
71.36
SMA100:
72.35
SMA200:
57.28
52-Wk Change:
122.94%
Stock Predictions
-
Is Apogee Therapeutics, Inc. stock public?Yes, Apogee Therapeutics, Inc. is a publicly traded company.
-
What is the Apogee Therapeutics, Inc. stock quote today?The Apogee Therapeutics, Inc. stock price is 84.34 USD today.
-
How to buy Apogee Therapeutics, Inc. stock online?You can buy Apogee Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 72.01 | 71.09 | 73.44 | 70.46 |
| Mar-17 | 70.51 | 69.85 | 70.68 | 67.91 |
| Mar-18 | 69.20 | 66.77 | 69.55 | 66.27 |
| Mar-19 | 66.54 | 68.50 | 69.59 | 66.01 |
| Mar-20 | 68.06 | 66.04 | 70.04 | 65.22 |
| Mar-23 | 77.32 | 79.24 | 81.46 | 76.18 |
| Mar-24 | 79.48 | 73.00 | 79.48 | 71.39 |
| Mar-25 | 74.59 | 78.53 | 85.04 | 73.98 |
| Mar-26 | 77.14 | 78.42 | 80.37 | 76.22 |
| Mar-27 | 77.69 | 77.82 | 80.25 | 76.29 |
| Mar-30 | 78.04 | 78.72 | 79.95 | 76.60 |
| Mar-31 | 80.35 | 84.17 | 84.85 | 80.21 |
| Apr-1 | 85.31 | 84.24 | 85.94 | 83.73 |
| Apr-2 | 82.69 | 84.34 | 84.90 | 81.68 |
Apogee Therapeutics, Inc. Earnings
Apogee Therapeutics, Inc. Earnings Report: Per Share Apogee Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Apogee Therapeutics, Inc. Forecast Revenue Growth
Apogee Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Apogee Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.
* Apogee Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.